These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 26970979)

  • 21. The presence of GM-CSF and IL-4 interferes with effect of TGF-beta1 on antigen presenting cells in patients with multiple sclerosis and in rats with experimental autoimmune encephalomyelitis.
    Xiao BG; Zhu WH; Lu CZ
    Cell Immunol; 2007 Sep; 249(1):30-6. PubMed ID: 18061154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monocytes and Monocyte-Derived Antigen-Presenting Cells Have Distinct Gene Signatures in Experimental Model of Multiple Sclerosis.
    Monaghan KL; Zheng W; Hu G; Wan ECK
    Front Immunol; 2019; 10():2779. PubMed ID: 31849962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FGF/FGFR Pathways in Multiple Sclerosis and in Its Disease Models.
    Rajendran R; Böttiger G; Stadelmann C; Karnati S; Berghoff M
    Cells; 2021 Apr; 10(4):. PubMed ID: 33924474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite.
    Platten M; Ho PP; Youssef S; Fontoura P; Garren H; Hur EM; Gupta R; Lee LY; Kidd BA; Robinson WH; Sobel RA; Selley ML; Steinman L
    Science; 2005 Nov; 310(5749):850-5. PubMed ID: 16272121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytosolic phospholipase A2α blockade abrogates disease during the tissue-damage effector phase of experimental autoimmune encephalomyelitis by its action on APCs.
    Thakker P; Marusic S; Stedman NL; Lee KL; McKew JC; Wood A; Goldman SJ; Leach MW; Collins M; Kuchroo VK; Wolf SF; Clark JD; Hassan-Zahraee M
    J Immunol; 2011 Aug; 187(4):1986-97. PubMed ID: 21746963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pituitary adenylate cyclase-activating polypeptide (PACAP) ameliorates experimental autoimmune encephalomyelitis by suppressing the functions of antigen presenting cells.
    Kato H; Ito A; Kawanokuchi J; Jin S; Mizuno T; Ojika K; Ueda R; Suzumura A
    Mult Scler; 2004 Dec; 10(6):651-9. PubMed ID: 15584490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Butylphthalide ameliorates experimental autoimmune encephalomyelitis by suppressing PGAM5-induced necroptosis and inflammation in microglia.
    Wang Y; Bi Y; Xia Z; Shi W; Li B; Li B; Chen L; Guo L
    Biochem Biophys Res Commun; 2018 Feb; 497(1):80-86. PubMed ID: 29407174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Daphnetin Alleviates Experimental Autoimmune Encephalomyelitis via Regulating Dendritic Cell Activity.
    Wang D; Lu Z; Zhang H; Jin SF; Yang H; Li YM; Shi LY
    CNS Neurosci Ther; 2016 Jul; 22(7):558-67. PubMed ID: 27013083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.
    Youssef S; Stüve O; Patarroyo JC; Ruiz PJ; Radosevich JL; Hur EM; Bravo M; Mitchell DJ; Sobel RA; Steinman L; Zamvil SS
    Nature; 2002 Nov; 420(6911):78-84. PubMed ID: 12422218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroimmunology of multiple sclerosis and experimental allergic encephalomyelitis.
    Stuerzebecher S; Martin R
    Neuroimaging Clin N Am; 2000 Nov; 10(4):649-68 ,vii-viii. PubMed ID: 11359717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prospects of minocycline in multiple sclerosis.
    Chen X; Ma X; Jiang Y; Pi R; Liu Y; Ma L
    J Neuroimmunol; 2011 Jun; 235(1-2):1-8. PubMed ID: 21565409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of dendritic cell properties by laquinimod as a mechanism for modulating multiple sclerosis.
    Jolivel V; Luessi F; Masri J; Kraus SH; Hubo M; Poisa-Beiro L; Klebow S; Paterka M; Yogev N; Tumani H; Furlan R; Siffrin V; Jonuleit H; Zipp F; Waisman A
    Brain; 2013 Apr; 136(Pt 4):1048-66. PubMed ID: 23518712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Organic Selenium Reaches the Central Nervous System and Downmodulates Local Inflammation: A Complementary Therapy for Multiple Sclerosis?
    de Toledo JHDS; Fraga-Silva TFC; Borim PA; de Oliveira LRC; Oliveira EDS; Périco LL; Hiruma-Lima CA; de Souza AAL; de Oliveira CAF; Padilha PM; Pinatto-Botelho MF; Dos Santos AA; Sartori A; Zorzella-Pezavento SFG
    Front Immunol; 2020; 11():571844. PubMed ID: 33193354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laquinimod, a quinoline-3-carboxamide, induces type II myeloid cells that modulate central nervous system autoimmunity.
    Schulze-Topphoff U; Shetty A; Varrin-Doyer M; Molnarfi N; Sagan SA; Sobel RA; Nelson PA; Zamvil SS
    PLoS One; 2012; 7(3):e33797. PubMed ID: 22479444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antigen presentation in the CNS by myeloid dendritic cells drives progression of relapsing experimental autoimmune encephalomyelitis.
    Miller SD; McMahon EJ; Schreiner B; Bailey SL
    Ann N Y Acad Sci; 2007 Apr; 1103():179-91. PubMed ID: 17376826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopaminergic Stimulation of Myeloid Antigen-Presenting Cells Attenuates Signal Transducer and Activator of Transcription 3-Activation Favouring the Development of Experimental Autoimmune Encephalomyelitis.
    Prado C; Gaiazzi M; González H; Ugalde V; Figueroa A; Osorio-Barrios FJ; López E; Lladser A; Rasini E; Marino F; Zaffaroni M; Cosentino M; Pacheco R
    Front Immunol; 2018; 9():571. PubMed ID: 29619030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controlled delivery of a metabolic modulator promotes regulatory T cells and restrains autoimmunity.
    Gammon JM; Tostanoski LH; Adapa AR; Chiu YC; Jewell CM
    J Control Release; 2015 Jul; 210():169-78. PubMed ID: 26002150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of Th1 differentiation by tryptophan supplementation in vivo.
    Lanz TV; Becker S; Mohapatra SR; Opitz CA; Wick W; Platten M
    Amino Acids; 2017 Jul; 49(7):1169-1175. PubMed ID: 28421297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain dendritic cells and macrophages/microglia in central nervous system inflammation.
    Fischer HG; Reichmann G
    J Immunol; 2001 Feb; 166(4):2717-26. PubMed ID: 11160337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunomodulation neuroprotection and remyelination - the fundamental therapeutic effects of glatiramer acetate: a critical review.
    Aharoni R
    J Autoimmun; 2014 Nov; 54():81-92. PubMed ID: 24934599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.